⌘K
Loading ticker…
Axsome Therapeutics, Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Axsome Therapeutics, Inc (AXSM) has a 3-month relative strength percentile of 89 and a leadership percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 73. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.7%, relative volume 9.41×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 89, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
AXSM is in a stage 2 uptrend, week 12. Currently in a 9-day base; basing ADR 3.3% (broad 3.8%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 7.8% / 41.3%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
AXSM is held by 8 ETFs as of Mar 2026. Top owner: VTI at 0.01% weight, $234M notional. Top 3 carry $575M.
Top 8 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.01% | $234M |
| IWMiShares Russell 2000 ETF | 0.24% | $171M |
| VBVanguard Small Cap ETF | 0.10% | $169M |
| VBKVanguard Small-Cap Growth ETF | 0.25% | $95M |
| VXFVanguard Extended Market ETF | 0.10% | $80M |
| IWOiShares Russell 2000 Growth ETF | 0.47% | $57M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $9M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 2.03% | $6M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AXSM Jan avg: 9.26% median: 7.00% win: 75% σ: 12.96% n: 4 2022-04-12 → 2026-05-29 | AXSM Feb avg: -2.48% median: -9.34% win: 25% σ: 14.88% n: 4 2022-04-12 → 2026-05-29 | AXSM Mar avg: -4.23% median: -5.25% win: 25% σ: 5.96% n: 4 2022-04-12 → 2026-05-29 | AXSM Apr avg: 1.22% median: -3.72% win: 40% σ: 18.07% n: 5 2022-04-12 → 2026-05-29 | AXSM May avg: -2.41% median: -0.45% win: 40% σ: 12.64% n: 5 2022-04-12 → 2026-05-29 | AXSM Jun avg: 14.87% median: 4.45% win: 50% σ: 26.11% n: 4 2022-04-12 → 2026-05-29 (current) | AXSM Jul avg: 3.88% median: 4.61% win: 75% σ: 5.91% n: 4 2022-04-12 → 2026-05-29 | AXSM Aug avg: 22.43% median: 11.30% win: 100% σ: 29.74% n: 4 2022-04-12 → 2026-05-29 | AXSM Sep avg: -10.57% median: -6.68% win: 50% σ: 14.61% n: 4 2022-04-12 → 2026-05-29 | AXSM Oct avg: 0.13% median: 0.13% win: 50% σ: 9.04% n: 4 2022-04-12 → 2026-05-29 | AXSM Nov avg: 22.74% median: 11.28% win: 100% σ: 24.96% n: 4 2022-04-12 → 2026-05-29 | AXSM Dec avg: 7.85% median: 12.35% win: 75% σ: 15.67% n: 4 2022-04-12 → 2026-05-29 |